Asthma Therapy
Recent findings from Center for Pneumology highlight research in asthma therapy
Published in Drug Week, December 21st, 2007
Data detailed in 'Interleukin-2 inhalation therapy temporarily induces asthma-like airway inflammation' have been presented. "Inhaled interleukin-2 (IL-2) is an effective and safe treatment in metastasing renal cell carcinoma (mRCC) but known to potentially elicit respiratory symptoms. The present study analyses the effects of IL-2 using a panel of measures including markers of airway inflammation," researchers in Germany report.
"Ten patients with mRCC (7m/3f; mean age, 63 yrs) were measured at baseline, 6-10 days after start of therapy (n=5, inhaled IL-2 only; n=5, inhaled IL-2 plus 1/11th of daily dose subcutaneously), and 16-29 days later under continuous combined...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-12-21)
More Articles from Drug Week
- Acute Lymphoblastic Leukemia
Study: Re-engineered Gleevec reduces heart risks - Algorithms
Child mental health experts issue psychiatric medication treatment guidelines for preschoolers - American Academy of Sleep Medicine
Napping a more effective countermeasure to sleepiness in younger people - Antifungals
Beating hospital yeast infection - Anxiety Disorders
Mental illness and drug addiction may co-occur due to disturbance in part of the brain - Cancer
Cancer patients may benefit from reporting symptoms online in real time - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
